Hold Rating for Koninklijke Philips N.V. Amid Sector Challenges and Company-Specific Uncertainties

In a report released today, Julien Ouaddour from Bank of America Securities reiterated a Hold rating on Koninklijke Philips N.V., with a price target of €28.00.

Julien Ouaddour has given his Hold rating due to a combination of factors impacting Koninklijke Philips N.V. The MedTech sector has experienced a de-rating, with a notable decline in 2025, driven by sector rotation, softer demand, and company-specific challenges. Although there is potential for growth with a strong EPS forecast, the sector still faces persistent headwinds such as tariffs and foreign exchange impacts, making stock selection crucial.
Philips has managed to settle significant legal issues in the US, which has been a positive development. However, ongoing investigations and the need for improved execution in meeting mid-term targets contribute to the cautious outlook. Despite potential for margin expansion, Philips needs to stabilize its market share in the Diagnosis & Treatment segment before a more favorable rating can be considered. The valuation has been adjusted, reflecting these mixed signals, resulting in a Hold recommendation.

In another report released on December 8, J.P. Morgan also maintained a Hold rating on the stock with a €19.60 price target.